Global Market Study on Soft Tissue Repair: Paradigm Shift from Conventional Technologies to Use of Biologics is Expected to Drive Market Growth By 2024


Soft Tissue Repair Market
  • Published On : Sep-2016 |
  • Pages : 201 Pages |
  • Format :

This Persistence Market Research (PMR) report examines the global soft tissue repair market for the period 2015–2024. The primary objective of the report is to offer updates and information related to market opportunities in the global soft tissue repair market.

Report Description

This Persistence Market Research (PMR) report examines the soft tissue repair market for the period 2015–2024. The primary objective of the report is to offer insights into developments in the soft tissue repair market affecting various segments of the global soft tissue repair market.

Soft tissue injury refers to the damage of muscles, ligaments and tendons occurred through direct and indirect trauma which is commonly characterized by tissue rapture, sprain and wear and tear. Soft tissue repair refers to the surgical procedure for repairing the damaged muscles, ligaments and other tissues. The repair process entails usage of biological materials such as allografts, xenografts, and synthetic mesh, to assist in tissue healing. Soft tissue repair processes are performed in hospitals, ambulatory surgical centers, and clinics.

Increasing incidence of osteoporosis-related factures among the geriatric population is expected to fuel demand for orthopedic surgeries. Moreover, medical expenses related to obesity have increased significantly over the last decade due to active lifestyle trends, which has resulted in increased implant volumes. Soft tissue repair product manufacturers are focused on increasing operations in developed countries of North America and Europe, where geriatric population is rising coupled with high incidence of age-related diseases. Moreover, increasing awareness among physicians about benefits of biological meshes such as reduced cost of surgery and reduced hospital stay post-surgery are expected to boost adoption of soft tissue repair products during the forecast period.

The global soft tissue repair market segmented as follows:

  • Soft tissue repair market, by product type
  • Soft tissue repair market, by application
  • Soft tissue repair market, by end use
  • Soft tissue repair market, by region

This report covers the global soft tissue repair market performance in terms of revenue contribution from various segments. This section also includes PMR analysis of key trends, drivers, restraints, and opportunities influencing growth of the global soft tissue repair market.

The soft tissue repair market report begins with an overview of soft tissue repair products, their application, and worldwide adoption of such products. This section emphasizes on influential growth factors of the global soft tissue repair market along with detailing of key trends, drivers, restraints, opportunities, and regulations. Impact analysis of key growth drivers and restraints based on the weighted average model along with key region-specific trends are included in the report to equip clients with crystal-clear and decision-making insights.  

On the basis of product type, the global soft tissue repair market is segmented into synthetic, allografts, xenografts, and alloplast. On the basis of application, the global soft tissue market is segmented into breast reconstruction, hernia repair, vaginal sling, dental problems, dermatology, orthopedics, and others. Orthopedics segment is further sub-segmented into dural repair, sports medication and tendon reinforcement, and others. On the basis of end users, the global soft tissue repair market is segmented into hospitals, ambulatory surgical centers, and clinics. A detailed analysis has been provided for every segment and sub-segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index, and BPS analysis. By product type, allografts segment is expected to register significant growth over the forecast period, owing to increasing adoption of allografts among physicians to treat patients.

The next section of the report highlights growth trends of the soft tissue repair market by regions. It provides a market outlook for 2015–2024 and sets the forecast within the context of the soft tissue repair market. The study discusses key regional trends contributing to growth of the soft tissue repair market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). North America is expected to emerge as the most dominant and attractive market over the forecast period.

The above sections by product type, application, end user, and region evaluate the present scenario and growth prospects of the soft tissue repair market for the period 2015–2024. We have considered 2014 as the base year and provided data for the forecast period.

Detailed company profiles include company-specific long- and short-term strategies, key offerings, and recent developments in the global soft tissue repair market. Key competitors covered in terms of manufacturers include B. Braun Melsungen AG, Baxter, C. R. Bard, Inc., Johnson & Johnson Private Limited, Stryker, Medtronic, Acera Surgical, Inc., Anthrex, Inc., and Acelity L.P. Inc.

Soft tissue repair is a procedure for restoring functions of damaged or injured tissues such as ligaments, muscles, and other tissues. Soft tissue repair can be achieved through surgical meshes such as allografts, xenografts, alloplasts, and synthetic. The global soft tissue repair market has been segmented on the basis of product type, application, end users, and key regions.    

Primary factors driving growth of the global soft tissue repair market are increasing disposable income and changing lifestyles among populations in developing economies. Additionally, rising geriatric population, increasing hernia repairs, and growing incidence of breast cancer are factors driving demand for wound care and soft tissue repair products globally. However, ethical concerns arising from cultural aversion towards the use of tissue from human cadavers and stringent regulations for biological meshes are expected to hamper growth of the global soft tissue repair market.

In terms of value, the global soft tissue repair market was valued at US$ 4.3 Bn in 2014 and is expected to reach US$ 7.3 Bn by 2024 end, expanding at a CAGR of 5.5% during the forecast period (2015–2024).

On the basis of product type, the global soft tissue repair market is segmented into allograft, xenograft, alloplast, and synthetic. In terms of value, allograft segment is expected to account for ~43% share of the global soft tissue repair market by 2024 end. This segment is expected to maintain its dominance and emerge the most attractive segment during the forecast period.

On the basis of application, the global soft tissue repair market is segmented into breast reconstruction, hernia repair, vaginal sling, dental problems, dermatology, orthopedics, and others. Orthopedics segment is further sub-segmented into dural repair, sports medication and tendon reinforcement, and others. In terms of value, orthopedic segment is expected to account for ~20% share of the global soft tissue repair market by 2024 end. This segment is expected to maintain its dominance and emerge the most attractive segment during the forecast period.

On the basis of end user, the global soft tissue repair market is segmented into hospitals, ambulatory surgical centers, and clinics. Increasing hospitalization rate for orthopedic surgeries is expected to boost revenue growth of hospitals segment in the global soft tissue repair market.

On the basis of region, the global soft tissue repair market is segmented into North America, Latin America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). In terms of value, North America accounted for over a third of the overall market revenue in 2015 and is estimated to continue to remain dominant by 2016 end. Europe and APAC are expected to register significant growth over the forecast period. Allografts segment accounts for a majority share in terms revenue of the global soft tissue repair market. Alloplasts are used for volume restoration and are usually preferred for applications in dermatology and breast reconstruction. Increasing incidence of trauma and burns are expected to fuel revenue growth of allografts and alloplast in the global soft tissue repair market in the near future.

Some of the key players identified in the global soft tissue repair drug market report include B. Braun Melsungen AG, Baxter, C. R. Bard, Inc., Johnson & Johnson Private Limited, Stryker, Medtronic, Acera Surgical, Inc., Anthrex, Inc., and Acelity L.P. Inc.

The report also provides company-specific strategies related to product development in tissue repair, market consolidation initiatives, and analyses of various market player’s specific strengths, weaknesses, opportunities, and threats.    

soft-tissue-repair-market

Company Profiles

  • Braun Melsungen AG
  • Baxter
  • C. R. Bard, Inc.
  • Johnson & Johnson Private Limited
  • Stryker
  • Integra LifeSciences Corporation
  • Medtronic
  • Acera Surgical, Inc.
  • Others
Back To Top